Monitoring apoptosis in real time

Cancer Journal

Volumn 8, Issue 2, 2002, Pages 82-92

  Green, Allan M ^a   Steinmetz, Neil D ^b  

^a Theseus Imaging Corporation   (United States)

^b NONE

Author keywords

Annexin; Apoptosis; Apoptotic index; Chemotherapy response; Necrosis; Phosphatidylserine; Scintigraphic imaging; Tc 99m rh annexin V

Indexed keywords

ANTHRACYCLINE; CASPASE; CELL NUCLEUS DNA; CYCLOPHOSPHAMIDE; FLUORESCEIN; FLUOROURACIL; LIPOCORTIN 5; METHOTREXATE; MITOXANTRONE; PACLITAXEL; PHOSPHATIDYLSERINE; TECHNETIUM 99M; THALLIUM 201; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; RECOMBINANT PROTEIN; TECHNETIUM;

ABSCESS; ACUTE HEART INFARCTION; APOPTOSIS; BONE MARROW; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CELL DEATH; CELL KILLING; CELL MEMBRANE; CLINICAL TRIAL; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DNA DEGRADATION; ENZYME ACTIVATION; FOLLOW UP; GRAFT REJECTION; HISTOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHOMA; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SARCOMA; SCINTIGRAPHY; SURVIVAL TIME; TUMOR BIOPSY; TUMOR CELL; ANIMAL; HEART INFARCTION; HEART MUSCLE; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ANNEXIN A5; APOPTOSIS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; NEOPLASMS; RADIOPHARMACEUTICALS; RECOMBINANT PROTEINS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036517518     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200203000-00002     Document Type: Review

References (37)

1. Finkel E. Does cancer therapy trigger cell suicide? Science 1999;286:2256-2258.
2. Hickman JA. Apoptosis induced by anti-cancer drugs. Cancer Metastasis Rev 1992;11:121-139.
3. Dive C, Evans CA, Whetton AD. Induction of apoptosis: new targets for cancer chemotherapy. Semin Cancer Biol 1992;3:417-427.
4. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-348.
5. Harrington EA, Fanidi A, Evans G. Oncogenes and cell death. Curr Opin Genet Dev 1994;4:120-129.
6. Lowe SW. Cancer therapy and p53. Curr Opin Oncol 1995;7:547-553.
7. Slichenmyer WJ, NelsonWG, Slebos RJ et al. Lossof p53 associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 1993;53:4164-4168.
8. Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J Lab Clin Med 1994;123:741-748.
9. Boersma AW, Nooter K, Oostrum RG, Stoter G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry 1996;24:123-130.
10. Martin SJ, Reutelingsperger CPM, McGahon AJ. Early redistribution of plasma membrane phosphatidalsyrene is a general feature of apoptosis regardless of the initiating stimulus: inhibition by over expression of Dcl-2 and Abl. J Exp Med 1995;182:1545-1556.
11. Zhang G, Gurtu V, Kain SR et al. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 1997;23:525-531.
12. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000;407:784-788.
13. Vermes I, Haanen C, Steffens-Nakken H et al. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995;184:39-51.
14. Vermes I, Haanen C, Richel DJ et al. Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematol 1997;98:8-13.
15. Blankenberg FG, Katsikis PD, Tait JF et al. In vivo detection and imaging of phosphatidylsyrene expression during programmed cell death. Proc Natl Acad Sci USA 1998;95:6349-6354.
16. Tait JF, Smith C. Site-specific mutagenesis of annexin V: role of residues from Arg-200 to Lys-207 in phospholipid binding. Arch Biochem Biophys 1991;288:141-144.
17. Abrams MJ, Juweid M, tenKate CI et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990; 31:2022-2028.
18. Blankenberg FG, Katsikis PD, Tait JF et al. Imaging of apoptosis (programmed cell death) with 99m-Tc annexin V. J Nucl Med 1999;40:184-191.
19. Blankenberg FG, Naumovski L, Tait JF et al. Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99m-Tc-radiolabeled annexin V. J Nucl Med 2001;42:309-315.
20. Blankenberg FG, Robbins RC, Stoot JH et al. Radionuclide imaging of acute lung transplant rejection with annexin V. Chest 2000;117:834-840.
21. Blankenberg FG, Tait JF, Blankenberg TA et al. Imaging macrophages and the apoptosis of gradual sites in a rodent module of subacute and chronic abscesses with radiolabelled monocyte chemotactic peptide-1 and annexin V. Eur J Nucl Med 2001;28:1384-1393.
22. Yang DJ, Azhdarinia A,Wu P et al. In vivo and in vitro measurement of apoptosis in breast cancer cells using Tc 99m-EC-annexin V. Cancer Biother Radiopharm 2001;16:73-83.
23. Mochizuki T, Kuge Y, Zhao S et al. Detection of tumor response following a single dose of chemotherapy with 99mTc-annexin V [abstract 313]. Presented at the 47th Annual Meeting of the Society of Nuclear Medicine, June 3-7, 2000, St. Louis MO.
24. Kasina S, Rao TN, Srinivasa A et al. Development in biological evaluation of the kit for preformed chelate Tc-99mradiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent. J Nucl Med 1991;32:1445-1451.
25. Kemerink GJ, Boersma HH, Thimister PW et al. Biodistribution and dosimetry of 99m-Tc-BTAP-annexin V in humans. Eur J Nucl Med 2001;28:1373-1378.
26. Kemerink GJ, Liem IH, Hofstra L et al. Patient dosimetry of intravenously administered Tc-99m annexin V. J Nucl Med 2001;42:382-387.
27. Tanaka M, Ito H, Adachi S et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75:426-433.
28. Gottlieb RA, Burleson KA, Kloner RA et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-1628.
29. Kajstura JW, Cheng K, Reiss et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
30. Saraste A, Pulkki K, Kallajoki M et al. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-323.
31. Dumont EA, Hofstra L, van Heerde WL et al. Cardiomyocyte death induced by myocardial ischemia and reprofusion: measurement with recombinant human annexin V in amousemodel. Circulation 2000;102:1564-1568.
32. Hofstra L, Liem IH, Dumont EA et al. Visualization of cell death in vivo in patients with acute myocardial infarction. Lancet 2000;356:209-212.
33. Archer CD, Ellis PA, Salte J et al. Induction of apoptosis and reduction in proliferation 24 hours after primary chemotherapy in early breast cancer [abstract 308]. Presented at the 35th Annual American Society of Clinical Oncology Meeting, May 15-18, 1999, Atlanta GA.
34. Chang J, Powles TJ, Ormerod M et al. Induction of apoptosis and decrease in proliferation predict response to systemic chemotherapy in breast cancer patients [abstract 2353]. Presented at the 35th Annual American Society of Clinical Oncology Meeting, May 15-18, 1999, Atlanta GA.
35. Belhocine TZ, Hustinx R, Jerusalem G et al. Tc-99m rh-annexin V (Apomate™) as a marker of apoptosis resulting from chemotherapy: preliminary results [abstract 1154]. Presented at the 47th Society of Nuclear Medicine Annual Meeting, June 3-7, 2000, St. Louis MO.
36. Steinmetz ND, Stopeck AT,Woolfenden JM et al. Imaging cell death in untreated and treated human tumors with Tc-99m annexin V prepared using the Apomatee kit [abstract 312]. Presented at the 48th Annual Meeting of the Society of Nuclear Medicine, June 23-27, 2001, Toronto.
37. Hofstra L, Dumont EA, Thimister PWL et al. In vivo detection of apoptosis in an intracardiac tumor. JAMA 2001;285:1841-1842.